Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today reported business updates and financial results for the third quarter ended September 30, 2024.
Read more at globenewswire.com
